← 產業報告目錄

Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-02-26頁數 292報告編號 MD4529

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The ventilators market is projected to reach USD 4.66 Billion by 2029 from USD 3.71 Billion in 2024 at a CAGR of 4.7% during the forecast period. Increscent respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and ageing populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology—safety, accuracy, and patient outcomes—prompt healthcare professionals to invest in newer respiratory support equipment. In sum, the increasing burden of respiratory illnesses is driving market growth. “The High-end ICU ventilators segment is accounted for the largest share of global ventilators market.” Premium ICU ventilators have the largest market share of the worldwide ventilators market due to the fact that they are essential in the treatment of life-threatening situations in intensive care units. Such high-end equipment has a comprehensive variety of ventilation modes, advanced monitoring systems, and improved safety features that are necessary for critical patients. With the aging worldwide population and prevalence of sophisticated respiratory diseases, healthcare facilities are aggressively investing in next-generation ICU solutions. In addition, ongoing development and strict standards imposed by regulative bodies support the use of these advanced devices, making them the go-to option in life-critical applications where the utmost patient outcomes must be achieved. “Combined mode ventilation has the largest market share in ventilators market.” Combined mode ventilators command the highest market share in the ventilators segment due to the fact that they provide the most advantageous aspects of volume- and pressure-controlled ventilation, allowing clinicians to customize respiratory support to the individual needs of a patient. The products allow clinicians to accurately control tidal volumes while also limiting pressure so that the lungs are not injured, thereby giving a versatile solution that can work in a number of clinical circumstances. Their paired, high-tech monitoring systems and automated adjustments do not only add convenience but also improve patient results. Accordingly, combined mode ventilators are in great demand among intensive care units with critically ill patients who need dynamic and flexible modes of ventilation. In addition, unbroken technology innovation, increased spending on healthcare facilities, and increasing instances of respiratory diseases have each played a role to drive combined mode ventilators to the top of the market. “Europe holds the second largest market share in the ventilators market.” Europe is the world's second-largest ventilator market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with high incidence of respiratory conditions and the ageing population, all ensure rising demand for invasive as well as non-invasive ventilators. Moreover, Europe is favored with a vibrant community of top-notch producers and never-ending innovation, leading to the development of ultra-modern technologies that improve patient results. Together with forward-looking healthcare measures and all-encompassing insurance coverage, Europe is a strong market for ventilators worldwide, guaranteeing its position as the second largest market share holder. A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below: • By Company Type: Tier 1–25%, Tier 2–40%, and Tier 3–35% • By Designation: C-level–20%, Director Level–38%, and Others–40% • By Region: North America–37%, Europe–28%, Asia Pacific–26%, Latin America- 6%, and Middle East and Africa– 1% and GCC Countries– 2% Prominent players in this market include ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Drägerwerk AG & CO. KGAA (Germany), ICU Medical, Inc. (US), Asahi Kasei Corporation (Japan), Air Liquide (France), Flexicare (Group) Limited (UK), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), GE Healthcare (US), Baxter (US), Vyaire Medical, Inc. (US), Hamilton Medical (Switzerland), Skanray Technologies (India), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Leistung Ingeniería SRL (Argentina), Avasarala Technologies Limited (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany) and AgVa Healthcare (India). Research Coverage: The market study covers the ventilators market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, age group, interface, mode, care setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market. This report provides insights on:  Analysis of Market Dynamics: Drivers (Rise in respiratory diseases Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide, Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases) restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns) opportunities (Cost-efficiency of home care services, growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations)  Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.  Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and region.  Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Drägerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).
目錄 Table of Contents
1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 STUDY SCOPE 26 1.3.1 MARKETS COVERED & REGIONS CONSIDERED 26 1.3.2 INCLUSIONS AND EXCLUSIONS 27 1.3.3 YEARS CONSIDERED 28 1.3.4 CURRENCY CONSIDERED 28 1.4 STAKEHOLDERS 29 1.5 SUMMARY OF CHANGES 29 1.6 IMPACT OF AI/GEN AI 30 2 RESEARCH METHODOLOGY 31 2.1 RESEARCH DATA 31 2.1.1 SECONDARY RESEARCH 32 2.1.1.1 Key data from secondary sources 33 2.1.2 PRIMARY RESEARCH 33 2.1.2.1 Key data from primary sources 34 2.1.2.2 Key industry insights 35 2.2 MARKET SIZE ESTIMATION 37 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 43 2.4 RESEARCH ASSUMPTIONS 44 2.5 RESEARCH LIMITATIONS 45 2.5.1 SCOPE-RELATED LIMITATIONS 45 2.5.2 METHODOLOGY-RELATED LIMITATIONS 45 2.6 RISK ASSESSMENT 45 3 EXECUTIVE SUMMARY 46 4 PREMIUM INSIGHTS 50 4.1 VENTILATORS MARKET OVERVIEW 50 4.2 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE AND COUNTRY (2024) 51 4.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52 4.4 VENTILATORS MARKET: REGIONAL MIX 52 4.5 VENTILATORS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 53   5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 5.2.1 DRIVERS 55 5.2.1.1 Rise in respiratory diseases 55 5.2.1.1.1 Increasing incidences of COPD and asthma 55 5.2.1.1.2 High prevalence of tobacco smoking 55 5.2.1.2 Urbanization and rising pollution levels 56 5.2.1.3 Rising obesity due to sedentary lifestyles 57 5.2.1.4 Growing geriatric population worldwide 57 5.2.1.5 Increasing preference for home care settings 58 5.2.1.6 Rising number of preterm births 58 5.2.1.7 Outbreak of infectious respiratory diseases 59 5.2.2 RESTRAINTS 59 5.2.2.1 Shortage of skilled medical workers 59 5.2.2.2 Excessive purchase of ventilators during COVID-19 59 5.2.2.3 Reimbursement concerns 60 5.2.3 OPPORTUNITIES 60 5.2.3.1 Cost-efficiency of home care services 60 5.2.3.2 Growth opportunities in emerging economies 61 5.2.4 CHALLENGES 61 5.2.4.1 Low awareness and inadequate resources in emerging economies 61 5.2.4.2 Harmful effects of respiratory devices on neonates 61 5.2.4.3 Supply chain disruptions 62 5.2.4.4 Global demand fluctuations 62 5.3 INDUSTRY TRENDS 63 5.3.1 RISING DEMAND FOR ENHANCED PORTABLE VENTILATORS 63 5.3.2 MARKET CONSOLIDATION 64 5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS 64 5.3.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATORS 65 5.4 TECHNOLOGY ANALYSIS 65 5.4.1 KEY TECHNOLOGIES 66 5.4.1.1 Sensor technologies 66 5.4.1.1.1 Flow sensors 66 5.4.1.1.2 Oxygen sensors 66 5.4.1.1.3 Pressure sensors 67 5.4.2 COMPLEMENTARY TECHNOLOGIES 67 5.4.2.1 E-nose technology 67 5.4.2.2 MEMS technology 68 5.4.2.3 Electrochemical technology 68 5.4.2.4 Paramagnetic technology 68 5.4.2.5 Wireless gas sensor technology 68 5.4.3 ADJACENT TECHNOLOGIES 69 5.4.3.1 High-flow nasal cannula (HFNC) devices 69 5.5 PRICING ANALYSIS 69 5.5.1 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER 69 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 70 5.6 VALUE CHAIN ANALYSIS 71 5.7 ECOSYSTEM ANALYSIS 72 5.8 SUPPLY CHAIN ANALYSIS 74 5.9 PORTER’S FIVE FORCES ANALYSIS 76 5.9.1 THREAT OF NEW ENTRANTS 77 5.9.2 THREAT OF SUBSTITUTES 77 5.9.3 BARGAINING POWER OF SUPPLIERS 77 5.9.4 BARGAINING POWER OF BUYERS 77 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 78 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 78 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 78 5.10.2 BUYING CRITERIA 80 5.11 REGULATORY ANALYSIS 81 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 5.11.2 REGULATORY FRAMEWORK 83 5.11.2.1 North America 83 5.11.2.1.1 US 83 5.11.2.1.2 Canada 83 5.11.2.2 Europe 83 5.11.2.3 Asia Pacific 84 5.11.2.3.1 Japan 84 5.11.2.3.2 China 84 5.11.2.3.3 India 84 5.11.2.3.4 South Korea 84 5.11.2.4 Latin America 85 5.11.2.4.1 Brazil 85 5.11.2.4.2 Mexico 85 5.11.2.5 Middle East 86 5.11.2.6 Africa 86 5.12 PATENT ANALYSIS 86 5.12.1 PATENT PUBLICATION TRENDS FOR VENTILATORS 86 5.13 TRADE ANALYSIS 89 5.13.1 EXPORT DATA FOR VENTILATORS (HS CODE 9018) 90 5.13.2 IMPORT DATA FOR VENTILATORS (HS CODE 9018) 91 5.14 KEY CONFERENCES AND EVENTS, 2023–2024 91 5.15 REIMBURSEMENT SCENARIO 92 5.16 UNMET NEEDS AND END-USER EXPECTATIONS 93 5.16.1 UNMET NEEDS IN VENTILATORS MARKET 93 5.16.2 END-USER EXPECTATIONS IN VENTILATORS MARKET 94 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95 5.18 INVESTMENT & FUNDING SCENARIO 95 5.19 ADJACENT MARKET ANALYSIS 97 5.19.1 RESPIRATORY DIAGNOSTICS MARKET 97 5.19.2 SLEEP APNEA DEVICES MARKET 98 5.20 IMPACT OF AI/GEN AI ON VENTILATORS MARKET 98 5.20.1 INTRODUCTION 98 5.20.2 FUTURE OF HEALTHCARE—BIG DATA AND AI 99 5.20.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT 99 6 VENTILATORS MARKET, BY TYPE 102 6.1 INTRODUCTION 103 6.2 INTENSIVE CARE VENTILATORS 103 6.2.1 HIGH-END ICU VENTILATORS 106 6.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market 106 6.2.2 MID-END ICU VENTILATORS 108 6.2.2.1 Higher affordability and accessibility to drive market 108 6.2.3 BASIC ICU VENTILATORS 110 6.2.3.1 Growing use in ambulatory care centers to drive market 110 6.3 PORTABLE/TRANSPORTABLE VENTILATORS 112 6.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET 112 7 VENTILATORS MARKET, BY AGE GROUP 114 7.1 INTRODUCTION 115 7.2 ADULT & PEDIATRIC VENTILATORS 115 7.2.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET 115 7.3 NEONATAL/INFANT VENTILATORS 117 7.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET 117 8 VENTILATION MARKET, BY INTERFACE 119 8.1 INTRODUCTION 120 8.2 HYBRID VENTILATION 120 8.2.1 RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET 120 8.3 NON-INVASIVE VENTILATION 121 8.3.1 RELIABILITY OF MECHANICAL DESIGNS TO DRIVE MARKET 121 8.4 INVASIVE VENTILATION 123 8.4.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 123 9 VENTILATORS MARKET, BY MODE 124 9.1 INTRODUCTION 125 9.2 COMBINED-MODE VENTILATORS 125 9.2.1 COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET 125 9.3 VOLUME-MODE VENTILATORS 126 9.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET 126 9.4 PRESSURE-MODE VENTILATORS 128 9.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET 128 9.5 OTHER VENTILATORS 129 10 VENTILATORS MARKET, BY CARE SETTING 131 10.1 INTRODUCTION 132 10.2 HOSPITALS & CLINICS 132 10.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET 132 10.3 AMBULATORY CARE CENTERS 133 10.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET 133 10.4 EMERGENCY MEDICAL SERVICES 135 10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET 135 10.5 HOME CARE SETTINGS 136 10.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET 136 11 VENTILATORS MARKET, BY REGION 138 11.1 INTRODUCTION 139 11.2 NORTH AMERICA 139 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 140 11.2.2 US 144 11.2.2.1 High prevalence of COPD to drive the market 144 11.2.3 CANADA 146 11.2.3.1 Increasing incidence of asthma to drive market 146 11.3 EUROPE 149 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 150 11.3.2 GERMANY 153 11.3.2.1 Rising healthcare spending to increase demand for high-end ventilators 153 11.3.3 FRANCE 156 11.3.3.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals 156 11.3.4 UK 158 11.3.4.1 Increasing healthcare expenditure to drive market growth 158 11.3.5 ITALY 161 11.3.5.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market 161 11.3.6 SPAIN 164 11.3.6.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth 164 11.3.7 NETHERLANDS 167 11.3.7.1 Rising prevalence of respiratory diseases to drive market 167 11.3.8 REST OF EUROPE 169 11.4 ASIA PACIFIC 172 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 172 11.4.2 JAPAN 177 11.4.2.1 Established healthcare system to increase adoption of respiratory care devices 177 11.4.3 CHINA 180 11.4.3.1 High prevalence of COPD and lung cancer to propel demand 180 11.4.4 INDIA 183 11.4.4.1 Rising focus of global players on the Indian market to drive adoption of advanced ventilators 183 11.4.5 AUSTRALIA 185 11.4.5.1 High prevalence of chronic lung diseases to drive demand for ventilators 185 11.4.6 REST OF ASIA PACIFIC 188 11.5 LATIN AMERICA 190 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 191 11.5.2 BRAZIL 193 11.5.2.1 Healthcare infrastructure improvement to support market growth 193 11.5.3 MEXICO 196 11.5.3.1 Rising obesity rate to increase incidence rate of respiratory diseases 196 11.5.4 ARGENTINA 199 11.5.4.1 Incidence of severe acute respiratory infections to drive market 199 11.5.5 REST OF LATIN AMERICA 201 11.6 MIDDLE EAST & AFRICA 204 11.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET 204 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 204 11.7 GCC COUNTRIES 206 11.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH 206 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 207   12 COMPETITIVE LANDSCAPE 210 12.1 OVERVIEW 210 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 2023 210 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET 210 12.3 REVENUE ANALYSIS, 2019–2023 211 12.4 MARKET SHARE ANALYSIS, 2023 212 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 214 12.5.1 STARS 214 12.5.2 EMERGING LEADERS 214 12.5.3 PERVASIVE PLAYERS 214 12.5.4 PARTICIPANTS 214 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 215 12.5.5.1 Company footprint 216 12.5.5.2 Region footprint 217 12.5.5.3 Type footprint 218 12.5.5.4 Age group footprint 219 12.5.5.5 Interface footprint 220 12.5.5.6 Mode footprint 221 12.5.5.7 Care setting footprint 222 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 223 12.6.1 PROGRESSIVE COMPANIES 223 12.6.2 RESPONSIVE COMPANIES 223 12.6.3 DYNAMIC COMPANIES 223 12.6.4 STARTING BLOCKS 223 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 225 12.6.5.1 Detailed list of key startups/SMEs 225 12.6.5.2 Competitive benchmarking of key startups/SMEs 225 12.7 VENTILATORS MARKET: R&D EXPENDITURE 226 12.8 COMPANY VALUATION & FINANCIAL METRICS 227 12.8.1 FINANCIAL METRICS 227 12.8.2 COMPANY VALUATION 227 12.9 BRAND/PRODUCT COMPARISON 228 12.10 COMPETITIVE SCENARIO 229 12.10.1 PRODUCT LAUNCHES & APPROVALS 229 12.10.2 DEALS 230 12.10.3 OTHER DEVELOPMENTS 231 13 COMPANY PROFILES 232 13.1 KEY PLAYERS 232 13.1.1 RESMED 232 13.1.1.1 Business overview 232 13.1.1.2 Products offered 233 13.1.1.3 Recent developments 234 13.1.1.3.1 Product launches & approvals 234 13.1.1.4 MnM view 234 13.1.1.4.1 Right to win 234 13.1.1.4.2 Strategic choices 234 13.1.1.4.3 Weaknesses and competitive threats 234 13.1.2 GETINGE AB 235 13.1.2.1 Business overview 235 13.1.2.2 Products offered 236 13.1.2.3 Recent developments 237 13.1.2.3.1 Product launches & approvals 237 13.1.2.3.2 Other developments 237 13.1.2.4 MnM view 237 13.1.2.4.1 Right to win 237 13.1.2.4.2 Strategic choices 238 13.1.2.4.3 Weaknesses and competitive threats 238 13.1.3 KONINKLIJKE PHILIPS N.V. 239 13.1.3.1 Business overview 239 13.1.3.2 Products offered 240 13.1.3.3 Recent developments 241 13.1.3.3.1 Other developments 241 13.1.3.4 MnM view 241 13.1.3.4.1 Right to win 241 13.1.3.4.2 Strategic choices 241 13.1.3.4.3 Weaknesses and competitive threats 242 13.1.4 DRÄGERWERK AG & CO. KGAA 243 13.1.4.1 Business overview 243 13.1.4.2 Products offered 244 13.1.4.3 Recent developments 245 13.1.4.3.1 Product launches & approvals 245 13.1.4.3.2 Deals 245 13.1.4.3.3 Other developments 246 13.1.5 ICU MEDICAL INC. 247 13.1.5.1 Business overview 247 13.1.5.2 Products offered 248 13.1.5.3 Recent developments 249 13.1.5.3.1 Deals 249 13.1.6 ASAHI KASEI CORPORATION 250 13.1.6.1 Business overview 250 13.1.6.2 Products offered 252 13.1.6.3 Recent developments 253 13.1.6.3.1 Deals 253 13.1.7 AIR LIQUIDE 254 13.1.7.1 Business overview 254 13.1.7.2 Products offered 255 13.1.7.3 Recent developments 256 13.1.7.3.1 Deals 256 13.1.8 FLEXICARE (GROUP) LIMITED 257 13.1.8.1 Business overview 257 13.1.8.2 Products offered 258 13.1.8.3 Recent developments 258 13.1.8.3.1 Deals 258 13.1.9 NIHON KOHDEN CORPORATION 259 13.1.9.1 Business overview 259 13.1.9.2 Products offered 260 13.1.9.3 Recent developments 261 13.1.9.3.1 Product launches 261 13.1.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 262 13.1.10.1 Business overview 262 13.1.10.2 Products offered 263 13.1.11 GE HEALTHCARE 264 13.1.11.1 Business overview 264 13.1.11.2 Products offered 265 13.1.11.3 Recent developments 265 13.1.11.3.1 Deals 265 13.1.12 BAXTER 266 13.1.12.1 Business overview 266 13.1.12.2 Products offered 267 13.1.12.3 Recent developments 268 13.1.12.3.1 Deals 268 13.1.13 VYAIRE MEDICAL, INC. 269 13.1.13.1 Business overview 269 13.1.13.2 Products offered 269 13.1.13.3 Recent developments 270 13.1.13.3.1 Deals 270 13.1.13.3.2 Other developments 270 13.1.14 HAMILTON MEDICAL 271 13.1.14.1 Business overview 271 13.1.14.2 Products offered 271 13.1.14.3 Recent developments 272 13.1.14.3.1 Product enhancements 272   13.2 OTHER PLAYERS 273 13.2.1 SKANRAY TECHNOLOGIES, LTD. 273 13.2.2 AXCENT MEDICAL GMBH 274 13.2.3 METRAN CO., LTD. 275 13.2.4 MAGNAMED 276 13.2.5 LEISTUNG INGENIERÍA SRL 277 13.2.6 AVASARALA TECHNOLOGIES LIMITED 277 13.2.7 AIRON CORPORATION 278 13.2.8 TRITON ELECTRONIC SYSTEMS LTD. 278 13.2.9 BIO-MED DEVICES, INC. 279 13.2.10 HEYER MEDICAL AG 279 13.2.11 AGVA HEALTHCARE 280 13.2.12 BIODESIGN INNOVATION LABS 280 13.2.13 NOCCARC ROBOTICS PVT LTD 281 13.2.14 UMBULIZER 281 13.2.15 SCHILLER HEALTHCARE INDIA PVT. LTD 282 13.2.16 AVI HEALTHCARE 282 14 APPENDIX 283 14.1 DISCUSSION GUIDE 283 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288 14.3 CUSTOMIZATION OPTIONS 290 14.4 RELATED REPORTS 290 14.5 AUTHOR DETAILS 291
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 28 TABLE 2 RISK ASSESSMENT 45 TABLE 3 DISORDERS AND DEATHS CAUSED DUE TO SMOKING, 2024 56 TABLE 4 INDUSTRY TRENDS IN VENTILATORS MARKET 63 TABLE 5 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2024 (USD) 69 TABLE 6 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2022–2024 (USD) 70 TABLE 7 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 73 TABLE 8 VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 76 TABLE 9 KEY STAKEHOLDERS IN BUYING PROCESS 78 TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS 80 TABLE 11 KEY BUYING CRITERIA FOR VENTILATORS 80 TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 17 LIST OF PATENTS IN VENTILATORS MARKET (2025) 88 TABLE 18 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS, 2023 (USD MILLION) 90 TABLE 19 EXPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND) 90 TABLE 20 IMPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND) 91 TABLE 21 VENTILATORS MARKET: KEY CONFERENCES AND EVENTS, 2023–2024 91 TABLE 22 REIMBURSEMENT SCENARIO IN VENTILATORS MARKET 93 TABLE 23 UNMET NEEDS IN VENTILATORS MARKET 93 TABLE 24 END-USER EXPECTATIONS IN VENTILATORS MARKET 94 TABLE 25 VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 103 TABLE 26 INTENSIVE CARE VENTILATORS: KEY PRODUCTS 104 TABLE 27 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 105 TABLE 28 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 105 TABLE 29 INTENSIVE CARE VENTILATORS MARKET, BY REGION, 2021–2029 (THOUSAND UNITS) 106 TABLE 30 HIGH-END ICU VENTILATORS: KEY PRODUCTS 106 TABLE 31 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 107 TABLE 32 HIGH-END ICU VENTILATORS MARKET, BY REGION, 2021–2029 (THOUSAND UNITS) 107 TABLE 33 MID-END ICU VENTILATORS: KEY PRODUCTS 108 TABLE 34 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 109 TABLE 35 MID-END ICU VENTILATORS MARKET, BY REGION, 2021–2029 (THOUSAND UNITS) 109 TABLE 36 BASIC ICU VENTILATORS: KEY PRODUCTS 110 TABLE 37 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 111 TABLE 38 BASIC ICU VENTILATORS MARKET, BY REGION, 2021–2029 (THOUSAND UNITS) 111 TABLE 39 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS 112 TABLE 40 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 113 TABLE 41 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021–2029 (THOUSAND UNITS) 113 TABLE 42 VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 115 TABLE 43 ADULT & PEDIATRIC VENTILATORS: KEY PRODUCTS 116 TABLE 44 ADULT & PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 116 TABLE 45 NEONATAL/INFANT VENTILATORS: KEY PRODUCTS 117 TABLE 46 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 118 TABLE 47 VENTILATION MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 120 TABLE 48 HYBRID VENTILATION MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 121 TABLE 49 NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 122 TABLE 50 INVASIVE VENTILATION MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 123 TABLE 51 VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 125 TABLE 52 COMBINED-MODE VENTILATORS: KEY PRODUCTS 125 TABLE 53 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 126 TABLE 54 VOLUME-MODE VENTILATORS: KEY PRODUCTS 127 TABLE 55 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 127 TABLE 56 PRESSURE-MODE VENTILATORS: KEY PRODUCTS 128 TABLE 57 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 129 TABLE 58 OTHER VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 130 TABLE 59 VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 132 TABLE 60 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION) 133 TABLE 61 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2029 (USD MILLION) 134 TABLE 62 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 135 TABLE 63 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2029 (USD MILLION) 137 TABLE 64 VENTILATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 139 TABLE 65 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 141 TABLE 66 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 142 TABLE 67 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 142 TABLE 68 NORTH AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 142 TABLE 69 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 143 TABLE 70 NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 143 TABLE 71 NORTH AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 143 TABLE 72 US: KEY MACROINDICATORS FOR VENTILATORS MARKET 144 TABLE 73 US: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 144 TABLE 74 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 145 TABLE 75 US: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 145 TABLE 76 US: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 145 TABLE 77 US: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 146 TABLE 78 US: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 146 TABLE 79 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 147 TABLE 80 CANADA: KEY MACROINDICATORS FOR VENTILATORS MARKET 147 TABLE 81 CANADA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 147 TABLE 82 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 148 TABLE 83 CANADA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 148 TABLE 84 CANADA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 148 TABLE 85 CANADA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 149 TABLE 86 CANADA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 149 TABLE 87 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 151 TABLE 88 EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 151 TABLE 89 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 151 TABLE 90 EUROPE: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 152 TABLE 91 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 152 TABLE 92 EUROPE: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 152 TABLE 93 EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 153 TABLE 94 GERMANY: KEY MACROINDICATORS FOR VENTILATORS MARKET 153 TABLE 95 GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 154 TABLE 96 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 154 TABLE 97 GERMANY: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 154 TABLE 98 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 155 TABLE 99 GERMANY: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 155 TABLE 100 GERMANY: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 155 TABLE 101 FRANCE: KEY MACROINDICATORS FOR VENTILATORS MARKET 156 TABLE 102 FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 156 TABLE 103 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 157 TABLE 104 FRANCE: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 157 TABLE 105 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 157 TABLE 106 FRANCE: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 158 TABLE 107 FRANCE: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 158 TABLE 108 UK: KEY MACROINDICATORS FOR VENTILATORS MARKET 159 TABLE 109 UK: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 159 TABLE 110 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 160 TABLE 111 UK: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 160 TABLE 112 UK: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 160 TABLE 113 UK: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 161 TABLE 114 UK: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 161 TABLE 115 ITALY: KEY MACROINDICATORS FOR VENTILATORS MARKET 162 TABLE 116 ITALY: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 162 TABLE 117 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 162 TABLE 118 ITALY: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 163 TABLE 119 ITALY: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 163 TABLE 120 ITALY: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 163 TABLE 121 ITALY: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 164 TABLE 122 SPAIN: KEY MACROINDICATORS FOR VENTILATORS MARKET 164 TABLE 123 SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 165 TABLE 124 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 165 TABLE 125 SPAIN: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 165 TABLE 126 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 166 TABLE 127 SPAIN: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 166 TABLE 128 SPAIN: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 166 TABLE 129 NETHERLANDS: KEY MACROINDICATORS FOR VENTILATORS MARKET 167 TABLE 130 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 167 TABLE 131 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 168 TABLE 132 NETHERLANDS: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 168 TABLE 133 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 168 TABLE 134 NETHERLANDS: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 169 TABLE 135 NETHERLANDS: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 169 TABLE 136 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 170 TABLE 137 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 170 TABLE 138 REST OF EUROPE: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 170 TABLE 139 REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 171 TABLE 140 REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 171 TABLE 141 REST OF EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 171 TABLE 142 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 175 TABLE 143 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 175 TABLE 144 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 175 TABLE 145 ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 176 TABLE 146 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 176 TABLE 147 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 176 TABLE 148 ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 177 TABLE 149 JAPAN: KEY MACROINDICATORS FOR VENTILATORS MARKET 178 TABLE 150 JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 178 TABLE 151 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 178 TABLE 152 JAPAN: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 179 TABLE 153 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 179 TABLE 154 JAPAN: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 179 TABLE 155 JAPAN: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 180 TABLE 156 CHINA: KEY MACROINDICATORS FOR VENTILATORS MARKET 180 TABLE 157 CHINA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 181 TABLE 158 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 181 TABLE 159 CHINA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 181 TABLE 160 CHINA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 182 TABLE 161 CHINA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION). 182 TABLE 162 CHINA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 182 TABLE 163 INDIA: KEY MACROINDICATORS FOR VENTILATORS MARKET 183 TABLE 164 INDIA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 183 TABLE 165 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 184 TABLE 166 INDIA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 184 TABLE 167 INDIA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 184 TABLE 168 INDIA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 185 TABLE 169 INDIA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 185 TABLE 170 AUSTRALIA: KEY MACROINDICATORS FOR VENTILATORS MARKET 186 TABLE 171 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 186 TABLE 172 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 186 TABLE 173 AUSTRALIA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 187 TABLE 174 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 187 TABLE 175 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 187 TABLE 176 AUSTRALIA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 188 TABLE 177 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 188 TABLE 178 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 189 TABLE 179 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 189 TABLE 180 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 189 TABLE 181 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 190 TABLE 182 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 190 TABLE 183 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 191 TABLE 184 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 191 TABLE 185 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 192 TABLE 186 LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 192 TABLE 187 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 192 TABLE 188 LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 193 TABLE 189 LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 193 TABLE 190 BRAZIL: KEY MACROINDICATORS FOR VENTILATORS MARKET 194 TABLE 191 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 194 TABLE 192 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 194 TABLE 193 BRAZIL: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 195 TABLE 194 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 195 TABLE 195 BRAZIL: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 195 TABLE 196 BRAZIL: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 196 TABLE 197 MEXICO: KEY MACROINDICATORS FOR VENTILATORS MARKET 196 TABLE 198 MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 197 TABLE 199 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 197 TABLE 200 MEXICO: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 197 TABLE 201 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 198 TABLE 202 MEXICO: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 198 TABLE 203 MEXICO: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 198 TABLE 204 ARGENTINA: KEY MACROINDICATORS FOR VENTILATORS MARKET 199 TABLE 205 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 199 TABLE 206 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 200 TABLE 207 ARGENTINA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 200 TABLE 208 ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 200 TABLE 209 ARGENTINA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 201 TABLE 210 ARGENTINA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 201 TABLE 211 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 202 TABLE 212 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 202 TABLE 213 REST OF LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 202 TABLE 214 REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 203 TABLE 215 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 203 TABLE 216 REST OF LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 203 TABLE 217 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 204 TABLE 218 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 205 TABLE 219 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 205 TABLE 220 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 205 TABLE 221 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 206 TABLE 222 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 206 TABLE 223 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 207 TABLE 224 GCC COUNTRIES: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 208 TABLE 225 GCC COUNTRIES: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION) 208 TABLE 226 GCC COUNTRIES: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION) 208 TABLE 227 GCC COUNTRIES: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 209 TABLE 228 GCC COUNTRIES: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION) 209 TABLE 229 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VENTILATORS MARKET, 2021–2025 210 TABLE 230 VENTILATORS MARKET: DEGREE OF COMPETITION 213 TABLE 231 VENTILATORS MARKET: REGION FOOTPRINT 217 TABLE 232 VENTILATORS MARKET: TYPE FOOTPRINT 218 TABLE 233 VENTILATORS MARKET: AGE GROUP FOOTPRINT 219 TABLE 234 VENTILATORS MARKET: INTERFACE FOOTPRINT 220 TABLE 235 VENTILATORS MARKET: MODE FOOTPRINT 221 TABLE 236 VENTILATORS MARKET: CARE SETTING FOOTPRINT 222 TABLE 237 VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 225 TABLE 238 VENTILATORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 225 TABLE 239 VENTILATORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 229 TABLE 240 VENTILATORS MARKET: DEALS, JANUARY 2021–JANUARY 2025 230 TABLE 241 VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 231 TABLE 242 RESMED: BUSINESS OVERVIEW 232 TABLE 243 RESMED: PRODUCTS OFFERED 233 TABLE 244 RESMED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 234 TABLE 245 GETINGE AB: BUSINESS OVERVIEW 235 TABLE 246 GETINGE AB: PRODUCTS OFFERED 236 TABLE 247 GETINGE AB: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 237 TABLE 248 GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 237 TABLE 249 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 239 TABLE 250 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 240 TABLE 251 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 241 TABLE 252 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 243 TABLE 253 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 244 TABLE 254 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 245 TABLE 255 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–JANUARY 2025 245 TABLE 256 DRÄGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 246 TABLE 257 ICU MEDICAL INC.: BUSINESS OVERVIEW 247 TABLE 258 ICU MEDICAL, INC.: PRODUCTS OFFERED 248 TABLE 259 ICU MEDICAL, INC.: DEALS, JANUARY 2021–JANUARY 2025 249 TABLE 260 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 250 TABLE 261 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 252 TABLE 262 ASAHI KASEI MEDICAL: DEALS, JANUARY 2021–JANUARY 2025 253 TABLE 263 AIR LIQUIDE: BUSINESS OVERVIEW 254 TABLE 264 AIR LIQUIDE: PRODUCTS OFFERED 255 TABLE 265 AIR LIQUIDE: DEALS, JANUARY 2021–JANUARY 2025 256 TABLE 266 FLEXICARE (GROUP) LIMITED: BUSINESS OVERVIEW 257 TABLE 267 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED 258 TABLE 268 FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021–JANUARY 2025 258 TABLE 269 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 259 TABLE 270 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 260 TABLE 271 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 261 TABLE 272 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: BUSINESS OVERVIEW 262 TABLE 273 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 263 TABLE 274 GE HEALTHCARE: BUSINESS OVERVIEW 264 TABLE 275 GE HEALTHCARE: PRODUCTS OFFERED 265 TABLE 276 GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025 265 TABLE 277 BAXTER: BUSINESS OVERVIEW 266 TABLE 278 BAXTER: PRODUCTS OFFERED 267 TABLE 279 BAXTER: DEALS, JANUARY 2021–JANUARY 2025 268 TABLE 280 VYAIRE MEDICAL, INC: BUSINESS OVERVIEW 269 TABLE 281 VYAIRE MEDICAL, INC: PRODUCTS OFFERED 269 TABLE 282 VYAIRE MEDICAL, INC: DEALS, JANUARY 2021–JANUARY 2025 270 TABLE 283 VYAIRE MEDICAL, INC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 270 TABLE 284 HAMILTON MEDICAL: BUSINESS OVERVIEW 271 TABLE 285 HAMILTON MEDICAL: PRODUCTS OFFERED 271 TABLE 286 HAMILTON MEDICAL: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025 272 _ FIGURE 1 VENTILATORS MARKET SEGMENTATION 26 FIGURE 2 RESEARCH DESIGN 31 FIGURE 3 PRIMARY SOURCES 33 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 36 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING, DESIGNATION, AND REGION 36 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. (NETHERLANDS) (2024) 38 FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION 39 FIGURE 10 DEMAND-SIDE MARKET SIZE ESTIMATION 40 FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2024–2029) 41 FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42 FIGURE 13 TOP-DOWN APPROACH 43 FIGURE 14 DATA TRIANGULATION METHODOLOGY 44 FIGURE 15 VENTILATORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 46 FIGURE 16 VENTILATORS MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION) 47 FIGURE 17 VENTILATORS MARKET, BY INTERFACE, 2024 VS. 2029 (USD MILLION) 47 FIGURE 18 VENTILATORS MARKET, BY MODE, 2024 VS. 2029 (USD MILLION) 48 FIGURE 19 VENTILATORS MARKET, BY CARE SETTING, 2024 VS. 2029 (USD MILLION) 48 FIGURE 20 GEOGRAPHICAL SNAPSHOT OF VENTILATORS MARKET 49 FIGURE 21 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET 50 FIGURE 22 INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024 51 FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 52 FIGURE 24 NORTH AMERICA WILL DOMINATE THE MARKET TILL 2029 52 FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD 53 FIGURE 26 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54 FIGURE 27 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE TYPE, 2024 56 FIGURE 28 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015–2023 58 FIGURE 29 ACQUISITIONS IN VENTILATORS MARKET, JANUARY 2019–NOVEMBER 2023 64 FIGURE 30 AVERAGE SELLING PRICE TREND FOR HIGH-END VENTILATORS, BY REGION, 2022–2024 (USD) 70 FIGURE 31 VENTILATORS MARKET: VALUE CHAIN ANALYSIS 72 FIGURE 32 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 73 FIGURE 33 SUPPLY CHAIN ANALYSIS 75 FIGURE 34 VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 76 FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS 79 FIGURE 36 KEY BUYING CRITERIA FOR VENTILATORS 80 FIGURE 37 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS), JANUARY 2015–FEBRUARY 2025 87 FIGURE 38 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95 FIGURE 39 NUMBER OF DEALS AND FUNDING IN VENTILATORS MARKET, 2019–2023 (USD MILLION) 96 FIGURE 40 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 96 FIGURE 41 VALUE OF INVESTOR DEALS, BY KEY PLAYERS, 2019–2023 (USD MILLION) 97 FIGURE 42 RESPIRATORY DIAGNOSTICS MARKET OVERVIEW 97 FIGURE 43 SLEEP APNEA DEVICES MARKET OVERVIEW 98 FIGURE 44 AI INTEGRATION FOR VENTILATORS 100 FIGURE 45 IMPACT OF AI/GEN AI ON VENTILATORS MARKET 101 FIGURE 46 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT 141 FIGURE 47 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT 174 FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2019–2023) 212 FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2023) 212 FIGURE 50 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 215 FIGURE 51 VENTILATORS MARKET: COMPANY FOOTPRINT 216 FIGURE 52 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 224 FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2022 VS. 2023) 226 FIGURE 54 EV/EBITDA OF KEY VENDORS 227 FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 227 FIGURE 56 BRAND/PRODUCT COMPARATIVE ANALYSIS 228 FIGURE 57 RESMED: COMPANY SNAPSHOT (2023) 233 FIGURE 58 GETINGE AB: COMPANY SNAPSHOT (2023) 236 FIGURE 59 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 240 FIGURE 60 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023) 244 FIGURE 61 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2023) 248 FIGURE 62 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2023) 251 FIGURE 63 AIR LIQUIDE: COMPANY SNAPSHOT (2023) 255 FIGURE 64 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023) 260 FIGURE 65 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023) 262 FIGURE 66 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 265 FIGURE 67 BAXTER: COMPANY SNAPSHOT (2023) 267

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們